semaglutide cause heart problems The weight-loss drug Wegovy lowered attack risk in a large trial Semaglutide reduces major cardiovascular events

Lean on your support systemprovider check-ins, online communities, or accountability partnersto normalize the experience and reinforce that resuming your dose this week returns you to full therapeutic benefit by week two

Since not all pregnancies are planned, more and more people were becoming pregnant while being treated with these drugs. Nowadays, GLP-1 receptor agonists such as Therefore, an increasing number of patients and healthcare providers will be looking for information on the safety of GLP-1 receptor agonists when used early in pregnancy

Read the full FLOW trial results and Plain Language Summary: #ClinicalTrials #MedicalResearch

doi: 10.1016/j.cmet.2018.12.020